hMPV

R&D

Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.

News

The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.